Kathleen Ogilvie
Company: Ventyx Biosciences
Job title: SVP
Seminars:
Clinical Outcomes from Phase 2 Trial of VTX2735 in Cryopyrin-Associated Periodic Syndromes (CAPS) 9:00 am
day: Day 1
Company: Ventyx Biosciences
Job title: SVP
day: Day 1